Michal Fisher

Insider · Director · CNSP

Michal Fisher files insider transactions with the SEC as a director of CNS Pharmaceuticals (CNSP). We hold 1 disclosed purchase or sale filed since 18 August 2026, 1 of them in the last 90 days.

Files forCNSP
Disclosed buys and sells1 in all, 1 in the last 90 days
Last disclosure18 August 2026

Positions held

1 post we hold — a term names its own dates; a run of filings only says when they filed

Filed 18 May 2026 — 18 May 2026Director · CNS Pharmaceuticals (CNSP)1 Form 4 line · source: SEC Form 4

Everything they disclosed

1 entry, newest first — one per disclosure report, one per Form 4 line

▲ bought on the open market 2,000 shares of CNS PharmaceuticalsSEC Form 418 August 2026Common Stock · traded 18 May 2026 · filed 18 August 2026

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.